The New Gravity: How Generative AI Remapped Innovation and What Academia Must Do Next.

Artificial intelligence is rapidly reshaping clinical research, diagnostics, health system operations, and medical education. Frontier generative AI development is increasingly concentrated in private industry, whose computational infrastructure, proprietary datasets, and capital exceed those of most academic institutions. Although not designed exclusively for medicine, these systems increasingly influence clinical applications. This shift raises a question for academic medical centers (AMCs): What role remains when leading AI systems emerge outside universities? This viewpoint examines industry's growing role in generative AI, clarifies AMCs' responsibilities, and proposes a framework for AI governance and literacy across undergraduate, graduate, and continuing medical education (CME). Rather than compete with industry on computational scale, AMCs should reinforce functions for which AMCs have distinctive strengths. These include (1) mechanistic inquiry linking algorithmic outputs to biological and pathophysiologic understanding; (2) interdisciplinary synthesis integrating clinical, ethical, legal, and sociotechnical perspectives; (3) independent and methodologically rigorous validation of clinical AI tools; and (4) institutional stewardship of ethical governance for patient populations that are often underrepresented in commercial datasets. As nonprofit institutions training clinicians, AMCs have a distinct role in safeguarding transparency, fairness, and accountability in AI-enabled health care. We position this 4-role framework to refine AI governance and translational medicine approaches, clarifying which responsibilities AMCs should retain while collaborating with industry. The approach includes longitudinal AI literacy training across undergraduate medical education, graduate medical education, and CME, standardized pathways for evaluating clinical AI, stronger conflict-of-interest safeguards, and complementary partnerships with industry and regulators. We also outline educational assessment methods and safety-monitoring processes, including competency-based assessment across undergraduate medical education, graduate medical education, and CME, postdeployment monitoring, and clear escalation triggers. Embedding verification habits and governance into training and practice can help ensure that generative AI supports clinical reasoning while preserving trust, equity, and scientific rigor. This viewpoint addresses academic leaders, curriculum committees, residency directors, faculty developers, and accreditors. Safe clinical AI requires sustained academic leadership.